InsightfulValue
← Home

Abbott Laboratories
Abbott Laboratories

Healthcare & biotech / Diversified healthcare products


📢 Press Releases

Date Press release
2025-05-27 09:00:00 Abbott Receives Fda Approval For Tendyne™, First-of-its-kind Device To Replace The Mitral Valve Without Open-heart Surgery
The tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (mac) tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral repair this approval expands abbott’s portfolio of minimally invasive structural heart therapies in the u.s. abbott park, ill., may 27, 2025 /prnewswire/ -- abbott (nyse: abt) today announced the u.s. food and drug administration (fda) has approved the company’s tendyne™ transcatheter mitral valve replacement (tmvr) system to treat people with mitral valve disease.
2025-05-15 09:05:00 Abbott’s Libre® Technology Is First Continuous Glucose Monitor Associated With Reduced Hospitalizations For Heart Complications In People With Diabetes
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with type 1 diabetes with prior severe low blood sugar episodes.1 this significant decrease is linked to the use of libre biowearable technology compared to traditional blood glucose monitors.1 results also show a reduction in hospitalization for cardiovascular complications in adults with type 2 diabetes on insulin using libre technology.2 abbott park, ill., may 15, 2025 /prnewswire/ -- abbott (nyse: abt) today announced results from its reflect real-world studies that show the use of freestyle libre® continuous glucose monitoring (cgm) technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes.
2025-05-01 09:00:00 Motoamerica Becomes First Sports Organization To Use Abbott’s Rapid Blood Test For Concussion Evaluation On-site At Races
The test, run on abbott’s portable i-stat ® alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes the test will be used by healthcare professionals in the medical facilities at all motoamerica races in 2025 abbott park, ill., and irvine, calif.
2025-04-29 09:05:00 Abbott Integrates Libre’s Data With Epic’s Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
Collaboration brings together freestyle libre® systems, the world’s leading continuous glucose monitoring technology (cgm)1 with epic, a healthcare software company, to streamline access to cgm data for healthcare organizations integration empowers u.s. clinicians to enhance patient care by incorporating libre’s data directly into their workflows abbott park, ill., april 29, 2025 /prnewswire/ -- abbott (nyse: abt), the global leader in continuous glucose monitoring (cgm) biowearable technology1, today announced that it has entered a first-of-its-kind agreement to integrate data from its world-leading1 libre cgm systems directly into epic’s electronic health record systems in the u.s. the collaboration aims to improve workflow efficiency for providers through epic’s aura software, which brings health systems together with diagnostics labs and medical device manufacturers.
2025-04-27 14:15:00 Abbott Highlights New Aveir™ Data, Initiates Trial For The Company’s Conduction System Pacing Technology
Late-breaking data from abbott’s groundbreaking first-in-human study demonstrated successful implantation of the company’s aveir conduction system pacing (csp) leadless pacemaker enrollment has also begun in the ascend csp pivotal clinical trial to evaluate abbott’s investigational csp implantable cardioverter-defibrillator (icd) lead conduction system pacing is an evolving technique specifically designed to deliver pacing to the left bundle branch area of the heart to restore its natural electrical rhythm san diego , april 27, 2025 /prnewswire/ -- abbott (nyse: abt) today announced late-breaking data from the aveir™ conduction system pacing (csp) acute clinical feasibility study, which demonstrated the safety and performance of the investigational aveir csp leadless pacemaker technology. the aveir csp acute clinical feasibility study is the world’s first assessment of a leadless pacemaker delivering conduction pacing to the heart’s left bundle branch (lbb) area.
2025-04-26 19:15:00 TmV3IENsaW 5pY2FsIFN0 dWR5IERhdG EgU2hvd2Nh c2UgTG9uZy 10ZXJtLCBT dXN0YWluZW QgQmVuZWZp dHMgT2YgQW Jib3R04oCZ cyBWb2x04o SiIFBmYSBT eXN0ZW0gRm 9yIFBhdGll bnRzIFdpdG ggQWZpYg==
TG9uZy10ZX JtIGRhdGEg ZnJvbSB0aG Ugdm9sdMKg Y2UgbWFyay BzdHVkeSBz aG93IHN0cm 9uZyByZXN1 bHRzIG91dC B0byAxMiBt b250aHMgaW 4gcGF0aWVu dHMgcmVjZW l2aW5nIHB1 bHNlZCBmaW VsZCBhYmxh dGlvbiAocG ZhKSB0aGVy YXB5IHdpdG ggdGhlIHZv bHTihKIgcG ZhIHN5c3Rl bSB0aGUgMT ItbW9udGgg cmVzdWx0cy BvZiB0aGUg dm9sdMKgY2 UgbWFyayBz dHVkeSBjb2 5maXJtIHRo ZSBsb25nLX Rlcm0gc2Fm ZXR5IGFuZC BlZmZpY2Fj eSBvZiB0aG Ugdm9sdCBw ZmEgc3lzdG VtIHRoZSBk YXRhIHdlcm UgcHJlc2Vu dGVkIGF0IH RoZSAyMDI1 IGhlYXJ0IH JoeXRobSBz b2NpZXR5IC hocnMpIGFu bnVhbCBtZW V0aW5nIGFi Ym90dCBwYX JrLCBpbGwu LCBhcHJpbC AyNiwgMjAy NSAvcHJuZX dzd2lyZS8g LS0gYWJib3 R0IChueXNl OiBhYnQpIG hhcyBhbm5v dW5jZWQgbm V3IGRhdGEg ZnJvbSBpdH Mgdm9sdMKg Y2UgbWFyay BzdHVkeSB0 aGF0IHNob3 cgc3Ryb25n IHNhZmV0eS BhbmQgZWZm aWNhY3kgb3 V0IHRvIDEy IG1vbnRocy Bmb3IgcGF0 aWVudHMgcm VjZWl2aW5n IHB1bHNlZC BmaWVsZCBh YmxhdGlvbi AocGZhKSB0 aGVyYXB5IH dpdGggdGhl IHZvbHTihK IgcGZhIHN5 c3RlbSBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBhdHJp YWwgZmlicm lsbGF0aW9u IChhZmliKS 4=
2025-04-16 07:30:00 QWJib3R0IF JlcG9ydHMg Rmlyc3QtcX VhcnRlciAy MDI1IFJlc3 VsdHMgQW5k IFJlYWZmaX JtcyBGdWxs LXllYXIgR3 VpZGFuY2U=
Rmlyc3QtcX VhcnRlciBn YWFwIGRpbH V0ZWQgZXBz IG9mICQwLj c2OyBhZGp1 c3RlZCBkaW x1dGVkIGVw cyBvZiAkMS 4wOSBmaXJz dC1xdWFydG VyIHJlcG9y dGVkIHNhbG VzIGdyb3d0 aCBvZiA0Lj AgcGVyY2Vu dDsgb3JnYW 5pYyBzYWxl cyBncm93dG ggb2YgNi45 IHBlcmNlbn Qgb3IgOC4z IHBlcmNlbn Qgd2hlbiBl eGNsdWRpbm cgY292aWQt MTkgdGVzdG luZy1yZWxh dGVkIHNhbG VzMSByZXBv cnRlZCBncm 9zcyBtYXJn aW4gb2YgNT IuOCBwZXJj ZW50IG9mIH NhbGVzOyBh ZGp1c3RlZC Bncm9zcyBt YXJnaW4gb2 YgNTcuMSBw ZXJjZW50LC B3aGljaCBy ZWZsZWN0cy BhIDE0MCBi YXNpcyBwb2 ludCBpbmNy ZWFzZSByZX BvcnRlZCBv cGVyYXRpbm cgbWFyZ2lu IG9mIDE2Lj MgcGVyY2Vu dCBvZiBzYW xlczsgYWRq dXN0ZWQgb3 BlcmF0aW5n IG1hcmdpbi BvZiAyMS4w IHBlcmNlbn QsIHdoaWNo IHJlZmxlY3 RzIGEgMTMw IGJhc2lzIH BvaW50IGlu Y3JlYXNlIG FiYm90dCBw YXJrLCBpbG wuLCBhcHJp bCAxNiwgMj AyNSAvcHJu ZXdzd2lyZS 8gLS0gwqBh YmJvdHQgKG 55c2U6IGFi dCkgdG9kYX kgYW5ub3Vu Y2VkIGZpbm FuY2lhbCBy ZXN1bHRzIG ZvciB0aGUg Zmlyc3QgcX VhcnRlciBl bmRlZCBtYX JjaCAzMSwg MjAyNS4=
2025-03-31 09:00:00 TmV3IExhdG UtYnJlYWtp bmcgRGF0YS BSZWluZm9y Y2UgQmVuZW ZpdHMgT2Yg QWJib3R04o CZcyBUcmlj bGlw4oSiIE ZvciBQZW9w bGUgV2l0aC BMZWFreSBU cmljdXNwaW QgSGVhcnQg VmFsdmU=
VHJpbHVtaW 5hdGXihKIg cGl2b3RhbC BkYXRhIHBy ZXNlbnRlZC BhdCB0aGUg YW1lcmljYW 4gY29sbGVn ZSBvZiBjYX JkaW9sb2d5 4oCZcyBhbm 51YWwgc2Np ZW50aWZpYy BzZXNzaW9u IChhY2MuMj UpIGFuZCBz aW11bHRhbm VvdXNseSBw dWJsaXNoZW QgaW4gY2ly Y3VsYXRpb2 4gc2hvdyB0 aGUgYWJib3 R0IHRyaWNs aXAgc3lzdG VtIHJlZHVj ZXMgaGVhcn QgZmFpbHVy ZSBob3NwaX RhbGl6YXRp b25zIHRoZS BsYXRlc3Qg cmVzdWx0cy BoaWdobGln aHQgc2lnbm lmaWNhbnQg aW1wcm92ZW 1lbnRzIGlu IHRyaWN1c3 BpZCByZWd1 cmdpdGF0aW 9uIGFuZCBx dWFsaXR5IG 9mIGxpZmUg dGhyb3VnaC B0d28geWVh cnMgYWJib3 R0IHBhcmss IGlsbC4sIG 1hcmNoIDMx LCAyMDI1IC 9wcm5ld3N3 aXJlLyAtLS BhYmJvdHQg KG55c2U6IG FidCkgdG9k YXkgYW5ub3 VuY2VkIGxh dGUtYnJlYW tpbmcgZGF0 YSBmcm9tIG l0cyB0cmls dW1pbmF0Ze KEosKgcGl2 b3RhbCB0cm lhbCB0aGF0 IHNob3cgdG hlIHRyaWNs aXDihKLCoH RyYW5zY2F0 aGV0ZXIgZW RnZS10by1l ZGdlIHJlcG FpciAodGVl cikgc3lzdG VtIHRvIHRy ZWF0IHRyaW N1c3BpZCBy ZWd1cmdpdG F0aW9uICh0 ciksIG9yIG EgbGVha3kg aGVhcnQgdm FsdmUsIG9m ZmVycyBzdW JzdGFudGlh bCBhbmQgc3 VzdGFpbmVk IGltcHJvdm VtZW50cyBp biB0aGUgc2 V2ZXJpdHkg b2YgdHIgYW Z0ZXIgdHdv IHllYXJzLg ==
2025-03-27 09:00:00 QWJib3R0IF JlY2VpdmVz IENlIE1hcm sgRm9yIEl0 cyBWb2x04o SiIFB1bHNl ZCBGaWVsZC BBYmxhdGlv biBTeXN0ZW 0gVG8gVHJl YXQgUGF0aW VudHMgV2l0 aCBBYm5vcm 1hbCBIZWFy dCBSaHl0aG 1z
QWJib3R04o CZcyB2b2x0 4oSiIHBmYS BzeXN0ZW0g aXMgZGVzaW duZWQgdG8g cHJvdmlkZS BhIG5ldyB0 aGVyYXB5IG 9wdGlvbiBm b3IgcGVvcG xlIGJhdHRs aW5nIGhlYX J0IHJoeXRo bSBkaXNvcm RlcnMgc3Vj aCBhcyBhdH JpYWwgZmli cmlsbGF0aW 9uIHB1bHNl ZCBmaWVsZC BhYmxhdGlv biDigJMgb3 IgcGZhIOKA kyB1c2VzIG hpZ2ggZW5l cmd5IGVsZW N0cmljYWwg cHVsc2VzIG ZvciBhYmxh dGlvbiBwcm 9jZWR1cmVz IHRoYXQgbW F5IG9mZmVy IGJlbmVmaX RzIHRvIHRh cmdldGluZy BhbmQgdHJl YXRpbmcgdG lzc3VlIGlu IHRoZSBoZW FydCBhYmJv dHTigJlzIH ZvbHQgcGZh IHN5c3RlbS BpcyBkZXNp Z25lZCB0by BvdmVyY29t ZSBsaW1pdG F0aW9ucyBv ZiBleGlzdG luZyBwZmEg c3lzdGVtcy wgcHJvdmlk aW5nIGltcH JvdmVkIHdv cmtmbG93cy BhbmQgYSBj bGVhcmVyIG luZGljYXRp b24gb2YgY2 9udGFjdCBi ZXR3ZWVuIH RoZSB2b2x0 IHBmYSBjYX RoZXRlciBh bmQgdGFyZ2 V0ZWQgdGlz c3VlIGFiYm 90dCBwYXJr LCBpbGwuLC BtYXJjaCAy NywgMjAyNS AvcHJuZXdz d2lyZS8gLS 0gYWJib3R0 IChueXNlOi BhYnQpIHRv ZGF5IGFubm 91bmNlZCBp dCBoYXMgcm VjZWl2ZWQg Y2UgbWFyay BpbiBldXJv cGUgZm9yIH RoZSB2b2x0 4oSiIHBmYS BzeXN0ZW0g dG8gdHJlYX QgcGF0aWVu dHMgYmF0dG xpbmcgYXRy aWFsIGZpYn JpbGxhdGlv biAoYWZpYi ku
2025-03-26 09:00:00 QWJib3R0IE hvc3RzIENv bmZlcmVuY2 UgQ2FsbCBG b3IgRmlyc3 QtcXVhcnRl ciBFYXJuaW 5ncw==
QWJib3R0IH BhcmssIGls bC4sIG1hcm NoIDI2LCAy MDI1IC9wcm 5ld3N3aXJl LyAtLSBhYm JvdHQgKG55 c2U6IGFidC kgd2lsbCBh bm5vdW5jZS BpdHMgZmly c3QtcXVhcn RlciAyMDI1 IGZpbmFuY2 lhbCByZXN1 bHRzIG9uIH dlZG5lc2Rh eSwgYXByaW wgMTYsIGJl Zm9yZSB0aG UgbWFya2V0 IG9wZW5zLg ==
2025-03-24 09:00:00 QWJib3R0IE luaXRpYXRl cyBOZXcgSW 50cmF2YXNj dWxhciBMaX Rob3RyaXBz eSBDbGluaW NhbCBUcmlh bCBUbyBJbX Byb3ZlIE91 dGNvbWVzIE luIFBhdGll bnRzIFdpdG ggQ29yb25h cnkgQXJ0ZX J5IERpc2Vh c2U=
Q29yb25hcn kgYXJ0ZXJ5 IGRpc2Vhc2 UgKGNhZCkg aXMgdGhlIG 1vc3QgY29t bW9uIGhlYX J0IGRpc2Vh c2UgYW5kIG 1vc3QgZnJl cXVlbnQgY2 F1c2Ugb2Yg ZGVhdGggaW 4gdGhlIHUu cy4sIHdpdG ggb3ZlciAy MCBtaWxsaW 9uIGFkdWx0 cyBhZmZlY3 RlZCBieSB0 aGlzIGNvbm RpdGlvbiBh YmJvdHTigJ lzIGludmVz dGlnYXRpb2 5hbCBjb3Jv bmFyeSBpbn RyYXZhc2N1 bGFyIGxpdG hvdHJpcHN5 IChpdmwpIH N5c3RlbSBv ZmZlcnMgYS BuZXcgcG90 ZW50aWFsIH RyZWF0bWVu dCBieSB1c2 luZyBzb3Vu ZCBwcmVzc3 VyZSB3YXZl cyB0byB0cm VhdCBhcnRl cmlhbCBjYW xjaXVtIGJs b2NrYWdlcy BhYmJvdHQg b2ZmZXJzIG EgY29tcHJl aGVuc2l2ZS B2YXNjdWxh ciBwb3J0Zm 9saW8gb2Yg dGVjaG5vbG 9naWVzIGRl c2lnbmVkIH RvIGFzc2Vz cywgdHJlYX QgYW5kIG1h bmFnZSBjYW xjaXVtIGJ1 aWxkdXAgaW 4gY29yb25h cnkgYXJ0ZX JpZXMgYWJi b3R0IHBhcm ssIGlsbC4s IG1hcmNoID I0LCAyMDI1 IC9wcm5ld3 N3aXJlLyAt LSBhYmJvdH QgKG55c2U6 IGFidCkgdG 9kYXkgYW5u b3VuY2VkIH RoYXQgdGhl IHUucy4gZm 9vZCBhbmQg ZHJ1ZyBhZG 1pbmlzdHJh dGlvbiAoZm RhKSBoYXMg YXBwcm92ZW QgYW4gaW52 ZXN0aWdhdG lvbmFsIGRl dmljZSBleG VtcHRpb24g KGlkZSkgZm 9yIGl0cyBj b3JvbmFyeS BpbnRyYXZh c2N1bGFyIG xpdGhvdHJp cHN5IChpdm wpIHN5c3Rl bSB0byBldm FsdWF0ZSB0 aGUgdHJlYX RtZW50IG9m IHNldmVyZS BjYWxjaWZp Y2F0aW9uIG luIGNvcm9u YXJ5IGFydG VyaWVzIHBy aW9yIHRvIH N0ZW50aW5n Lg==
2025-03-04 11:38:00 Q2FnZW50IF Zhc2N1bGFy IEFwcG9pbn RzIFBhdWwg V2lsc29uIE FzIENoaWVm IENvbW1lcm NpYWwgT2Zm aWNlciBUby BEcml2ZSBH cm93dGggQW 5kIE1hcmtl dCBFeHBhbn Npb24=
V2F5bmUsIH Blbm4uLS0o YnVzaW5lc3 Mgd2lyZSkt LSAjY2xpLS 1jYWdlbnQg dmFzY3VsYX IsIGluYy4s IHRoZSBleG NsdXNpdmUg ZGV2ZWxvcG VyIG9mIHNl cnJhdGlvbi B0ZWNobm9s b2d5IGZvci B2ZXNzZWwg ZGlsYXRpb2 4gaW4gZW5k b3Zhc2N1bG FyIGludGVy dmVudGlvbn MsIHRvZGF5 IGFubm91bm NlZCB0aGUg YXBwb2ludG 1lbnQgb2Yg cGF1bCB3aW xzb24gYXMg Y2hpZWYgY2 9tbWVyY2lh bCBvZmZpY2 VyIChjY28p LiBpbiB0aG lzIHJvbGUs IG1yLiB3aW xzb24gd2ls bCBsZWFkIH RoZSBjb21w YW554oCZcy Bjb21tZXJj aWFsIHN0cm F0ZWd5LCBv dmVyc2VlaW 5nIHNhbGVz LCBtYXJrZX RpbmcsIGNs aW5pY2FsIH Byb2dyYW1t aW5nLCBhbm QgYnVzaW5l c3MgZGV2ZW xvcG1lbnQg aW5pdGlhdG l2ZXMuIGhp cyBsZWFkZX JzaGlwIHdp bGwgaGVscC BleHBhbmQg YXdhcmVuZX NzLCBhY2Nl bGVyYXRlIG dyb3d0aCwg YW5kIHN0cm VuZ3RoZW4g bWFya2V0IH Bvc2l0aW9u aW5nIG9mIG NhZ2VudC4=
2025-02-21 10:48:00 QWJib3R0IE RlY2xhcmVz IDQwNXRoIE NvbnNlY3V0 aXZlIFF1YX J0ZXJseSBE aXZpZGVuZA ==
QWJib3R0IH BhcmssIGls bC4sIGZlYi 4gMjEsIDIw MjUgL3Bybm V3c3dpcmUv IC0tIHRoZS Bib2FyZCBv ZiBkaXJlY3 RvcnMgb2Yg YWJib3R0IC hueXNlOiBh YnQpIHRvZG F5IGRlY2xh cmVkIGEgcX VhcnRlcmx5 IGNvbW1vbi BkaXZpZGVu ZCBvZiA1OS BjZW50cyBw ZXIgc2hhcm Uu
2025-02-04 11:27:00 QWJib3R04o CZcyDigJlh Ym92ZSBUaG UgQmlhc+KA mSBGaWxtIF JldmVhbHMg TWlzY29uY2 VwdGlvbnMg Q2FuIEltcG FjdCBEaWFi ZXRlcyBDYX Jl
TmV3IHN1cn ZleSBzaG93 cyA0MCUgb2 YgcGVvcGxl IGxpdmluZy B3aXRoIGRp YWJldGVzIG hhdmUgc2tp cHBlZCBvci BtaXNzZWQg YSBkb2N0b3 LigJlzIGFw cG9pbnRtZW 50IGR1ZSB0 byBzaGFtZS BvciBzdGln bWExIDcwJS BvZiBwZW9w bGUgd2l0aC BkaWFiZXRl cyBzYWlkIH N1cHBvcnRp dmUgY29tbW VudHMgZnJv bSBvdGhlcn MgY2FuIHNp Z25pZmljYW 50bHkgYm9v c3QgdGhlaX IgbW90aXZh dGlvbiB0by BtYW5hZ2Ug dGhlaXIgY2 9uZGl0aW9u MSBhYmJvdH QgbGF1bmNo ZXMgZmlsbS B0aGF0IGhp Z2hsaWdodH MgY2hhbGxl bmdlcyBvZi BsaXZpbmcg bGlmZSB3aX RoIGRpYWJl dGVzIGFiYm 90dCBwYXJr LCBpbGwuLC BmZWIuIDQs IDIwMjUgL3 BybmV3c3dp cmUvIC0twq DigJlvbmUg Y3VwY2FrZS B3b27igJl0 IGtpbGwgeW 91LOKAmSDi gJlp4oCZbS Bnb2luZyB0 byBnZXQgZG lhYmV0ZXMg anVzdCBsb2 9raW5nIGF0 IHRoYXQs4o CZIOKAmXRo YXQgcGVyc2 9uIGRvZXNu 4oCZdCBsb2 9rIGxpa2Ug dGhleSBoYX ZlIGRpYWJl dGVzLg==
2025-01-22 07:00:00 QWJib3R0IF JlcG9ydHMg Rm91cnRoLX F1YXJ0ZXIg QW5kIEZ1bG wteWVhciAy MDI0IFJlc3 VsdHM7IElz c3VlcyAyMD I1IEZpbmFu Y2lhbCBPdX Rsb29r
Rm91cnRoLX F1YXJ0ZXIg c2FsZXMgb2 YgJDExLjAg YmlsbGlvbj sgZnVsbC15 ZWFyIDIwMj Qgc2FsZXMg b2YgJDQyLj AgYmlsbGlv biBmb3VydG gtcXVhcnRl ciByZXBvcn RlZCBzYWxl cyBpbmNyZW FzZWQgNy4y IHBlcmNlbn Q7IG9yZ2Fu aWMgc2FsZX MgZ3Jvd3Ro IGZvciB0aG UgdW5kZXJs eWluZyBiYX NlIGJ1c2lu ZXNzIGluY3 JlYXNlZCAx MC4xIHBlcm NlbnQxIGZ1 bGwteWVhci AyMDI0IHJl cG9ydGVkIH NhbGVzIGlu Y3JlYXNlZC A0LjYgcGVy Y2VudDsgb3 JnYW5pYyBz YWxlcyBncm 93dGggZm9y IHRoZSB1bm Rlcmx5aW5n IGJhc2UgYn VzaW5lc3Mg aW5jcmVhc2 VkIDkuNiBw ZXJjZW50Mi BhYmJvdHQg cHJvamVjdH MgZnVsbC15 ZWFyIDIwMj Ugb3JnYW5p YyBzYWxlcy Bncm93dGgg dG8gYmUgaW 4gdGhlIHJh bmdlIG9mID cuNSUgdG8g OC41JSBhYm JvdHQgcGFy aywgaWxsLi wgamFuLiAy MiwgMjAyNS AvcHJuZXdz d2lyZS8gLS 0gYWJib3R0 IChueXNlOi BhYnQpIHRv ZGF5IGFubm 91bmNlZCBm aW5hbmNpYW wgcmVzdWx0 cyBmb3IgdG hlIGZvdXJ0 aCBxdWFydG VyIGVuZGVk IGRlYy4gMz EsIDIwMjQu
Abbott Laboratories

📰 Browse additional press releases for Abbott Laboratories!

Sign up for free or log in

📝 Join us and grab your copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal